Serological detection of invasive pulmonary aspergillosis in severely ill COVID-19 patients
Diagnostic Microbiology and Infectious Disease · vol. 114 (3) · 117212-117212
المخرجات
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
9 output Results for «Critically ill»
Diagnostic Microbiology and Infectious Disease · vol. 114 (3) · 117212-117212
Clinical and Applied Thrombosis/Hemostasis · vol. 29 · 10760296231218216-10760296231218216
The use of erythropoietin-stimulating agents (ESAs) as adjunctive therapy in critically ill patients with COVID-19 may have a potential benefit. This study aims to evaluate the effect of ESAs on the clinical outcomes of critically ill COVID-19 patients. A multicenter, retrospective cohort study was conducted from 01-03-2020 to 31-07-2021. We included adult patients who were ≥ 18 years old with a confirmed diagnosis of COVID-19 infection and admitted to intensive care units (ICUs). Patients were categorized depending on ESAs administration during their ICU stay. The primary endpoint was the length of stay; other endpoints were considered secondary. After propensity score matching (1:3), the overall included patients were 120. Among those, 30 patients received ESAs. A longer duration of ICU and hospital stay was observed in the ESA group (beta coefficient: 0.64; 95% CI: 0.31-0.97; P = < .01, beta coefficient: 0.41; 95% CI: 0.12-0.69; P = < .01, respectively). In addition, the ESA group's ventilator-free days (VFDs) were significantly shorter than the control group. Moreover, patients who received ESAs have higher odds of liver injury and infections during ICU stay than the control group. The use of ESAs in COVID-19 critically ill patients was associated with longer hospital and ICU stays, with no survival benefits but linked with lower VFDs.
European Scientific Journal ESJ · vol. 19 (33) · 116-116
The intensive care unit (ICU) is a specialized area of hospitals dealing with the diagnosis, management, and follow-up of critically ill patients. Moreover, Critical Care Nurses (CCNs) should have strong analytical, interpersonal, and decision-making skills. Objectives: This study aimed to assess the effect of the teaching program on CCNs’ performance during the measurement of central venous pressure (CVP). Design: A quasi-experimental design was used. Methods: The study was conducted in the critical care units at Al-Assad University Hospital, Damascus from June to September 2020. All available registered nurses working in the previous ICUs were included. An observational checklist sheet was developed by the researcher after reviewing the related literature. Each nurse was observed once for each procedure during different shifts. The researcher developed and designed the teaching program based on the nurses’ needs according to their performance during the initial assessment. Results: The results showed that the performance of the nurses improved after the program. The best performance was for nurses in the age group between 20 and 24 years, nurses with a master’s degree, and nurses with less than five years of experience, while the level of knowledge and practice of the studied nurses was average and poor before the teaching program. Overall, this study found a statistically significant relationship before and after the implementation of the program. Conclusion: There has been an obvious improvement in nurses’ knowledge and performance after the teaching program. It is essential to help nurses expand their knowledge and practices to provide high-quality care and promote patient safety.
Malaysian Journal of Medical Sciences · vol. 29 (5) · 17-23
Sepsis is a medical emergency that involves a systemic immunological response due to an infection, resulting in the end-stage-organs malfunction and death. It is associated with high mortality rate despite a better understanding of the disease pathology and the mechanism involved. This review was designed to summarise the available evidences regarding the adequacy of the empiric antimicrobial therapy (EAMT), its predictors and its impact on the outcomes in intensive care unit (ICU) sepsis patients. Providing an adequate EAMT is considered one of the cornerstones of sepsis management as it has been found to be associated with better survival and is a good predictor for shorter ICU-length-of-stay. In contrast, inadequate EAMT in sepsis patients is associated with poor clinical outcomes including increased mortality and prolonged hospital stay. Evidence from this review suggest that it is important to identify determinants of inadequate EAMT to optimise the antimicrobial therapy provided to sepsis patients. Predictors of inadequate EAMT included co-morbidities (cancer), source and type of infection, higher Acute Physiology and Chronic Health Evaluation (APACHI-II) score and long hospital stay prior to the infection. As EAMT is considered as one of the effective treatment strategies to prevent sepsis associated death, healthcare providers should ensure the adequate antimicrobial therapy is provided for sepsis patients to improve and optimise their management.
Qatar medical journal · vol. 2022 (1) · 17-17
BACKGROUND: Tracheostomy is among the oldest and most common surgical procedures for critically ill patients. Over the past decade, tracheostomy practice has changed regarding its indication, timing, technique, decannulation, and follow-up procedures. A systematic assessment tool for tracheostomy could maximize the quality of care and improve patient outcomes. This study develops a tool for systematically evaluating tracheostomy-related practices, assesses its validity and reliability, and conducts pilot testing of the tool. METHODS: The questionnaire development process involved three rounds using the Delphi technique with eight experts in airway management. The experts were selected from multiple healthcare specialties and workplace backgrounds. There was a two-week interval between each discussion round. In February 2019, the questionnaire themes and statements were identified through qualitative content analysis. Subsequently, in March 2019, the developed tool was emailed to 31 heads of tracheostomy care teams at multiple national hospitals for further validity and reliability assessment. RESULTS: The developed tool demonstrated reliability of 0.975. Tracheostomy-related practices showed acceptable levels in all 31 assessed hospitals with areas for improvement in the long-term follow-up domain. CONCLUSION: This study designed a tool for the comprehensive assessment of tracheostomy-related practices. It can be used to monitor institutional outcomes, which can reduce costs. Moreover, this tool can be employed to track the improvement or deterioration of tracheostomy-related procedures and long-term follow-up to facilitate institutional progress. In addition, this tool could be used for formative and summative assessments of tracheotomy practices at national and international levels.
Current Medical Research and Opinion · vol. 37 (7) · 1085-1097
Introduction Favipiravir is a repurposed drug to treat coronavirus 2019 (COVID-19). Due to a lack of available real-world data, we assessed its effectiveness and safety in moderately to critically ill COVID-19 patients.Methods This retrospective study was conducted in two public/specialty hospitals in Saudi Arabia. We included patients ≥18 years) admitted April–August 2020 with confirmed SARS-CoV-2 diagnosed by real-time polymerase chain reaction (RT-PCR) from nasopharyngeal swab. Patients received either favipiravir (1800 mg or 1600 mg twice daily loading dose, followed by 800 mg or 600 mg twice daily) or supportive-care treatment. Patients were excluded if they were outside the study period, classified as having a mild form of the disease per WHO criteria, or had an incomplete patient file. Kaplan–Meier (KM) models were used to estimate median time to discharge. Discharge ratios, progression to mechanical ventilation, and mortality outcomes were estimated across the severity spectrum using Cox proportional-hazards models. As a sensitivity analysis, we performed propensity score-matching (PSM) analysis.Results Overall, median time to discharge was 10 days (95%CI = 9–10) in the favipiravir arm versus 15 days (95%CI = 14–16) in the supportive-care arm. The accelerated discharge benefit was seen across the COVID-19 spectrum of severity. The adjusted discharge ratio was 1.96 (95%CI = 1.56–2.46). Progression to mechanical ventilation was slower with favipiravir (HRadj = 0.10, 95%CI = 0.04–0.29). There was no significant effect on mortality (HRadj = 1.56, 95%CI = 0.73–3.36). There was a statistically non-significant trend toward worse outcomes in the critical category (HRadj = 2.80, 95%CI = 0.99–7.89). Age was an independent risk factor for mortality in mechanically ventilated patients. PSM analyses confirmed these findings.Conclusion Favipiravir was associated with clinical benefits, including accelerated discharge rate and less progression to mechanical ventilation; however, no overall mortality benefits were seen across the severity spectrum.
Pakistan Journal of Medical and Health Sciences · vol. 15 (10) · 2838-2840
Background: Over the past decade, excessive use of Colistin against multidrug-resistant, Gram-negative bacteria have resulted in the evolution of resistance to Colistin. Objective: To evaluate efficacy of Colistin against multidrug-resistant organisms (MDRO), the emergence of Colistin resistance and its effects on clinical outcomes. Study Design: Retrospective study Place and Duration of Study: King Saud Medical City (KSMC) from 1st October 2015 till 31st January 2016. Methodology: Forty-three patients, resistant to Colistin on blood culture and sensitivity were enrolled. Results: Colistin was not effective at breaking the MDRO. The results revealed no significant impact of Colistin on site of infection such as chest, urinary tract or skin (p=0.612), types of organisms (p=0.629), length of hospital stay and the IV Colistin days (p=0.097 and p=0.166 respectively) in the past 12 months. The positive finding was that more than two third (76.7%) of the ICU patients were alive. Conclusion: Emergence of Multi drug resistance organism is matter of global concern that caused the ineffectiveness of many potent antibiotics and led to the drastic clinical outcomes. Collaboration between medical, paramedical, and administrative staff, with strict implementation of preventive protocol can slow down the velocity of microbial multidrug resistance. Keywords: Multi-drug resistant, Colistin, Outbreak, Intensive care unit, critically ill patients
Journal of Lung Pulmonary & Respiratory Research · vol. 7 (2) · 51-54
The new coronavirus disease which emerged in Wuhan late in 2019 is caused by SARS CoV2, it was named COVID-19 and declared a pandemic by the world health organization (WHO). Human coronavirus normally causes mild disease. The new COVID-19 emerged from bats to human and it’s associated with highly infectious disease. The disease clinical features range from an asymptomatic state to mild fever, cough, severe respiratory disease, and multiple organ failures. The disease is confirmed by detecting the virus genome using polymerase chain reaction and antibody detection is used for screening. Radiologic imaging is nonspecific but can help in staging lung involvement. Treatment of patients with COVID-19 is generally supportive, however oxygen and ventilatory support might be needed in some of the cases. Dexamethasone proved to decrease mortality in critically ill patients, but up to date no specific treatment or vaccine is available and many drugs are under clinical trials including ritonavir and remdesivir. Hydroxychloroquine (HCQ) which is an old antimalarial drug, has given hope, but now it’s a victim for information uncertainty and contravention of clinical reports. The objective of this article is to review the current reports on hydroxychloroquine efficacy and safety in the treatment of COVID 19 patients.
PubMed · vol. 49 (3) · 197-201
OBJECTIVES: To assess students' perception for critical care training during respiratory care hospital placements. METHODS: Cross-sectional descriptive design survey, about demographics, perceptions for involvement in caring for critical patients, and the perceived improvement in knowledge, skills, and confidence during hospital placement. RESULTS: Of the 80 students placed for hospital respiratory care training, 61 completed the study. Thirty-seven of the responders were males (60%). Forty-nine students (80%) agreed on the usefulness of the placements in preparing them for critical care situations. Students who completed practicum I agreed on the importance of simulation-based training before placements, and the involvement in caring for critically ill adults but not for pediatric or neonatal patients. Most of the students disagreed or strongly disagreed about involvement in caring for critically ill pediatric patients and neonates and denied any improvement in their confidence in caring for them. CONCLUSION: The majority of students perceived critical care placements as being more positive than negative. Responses that were more positive were among students while placed in adult intensive care. Students perceived that they were not involved and had no improvement in confidence when caring for pediatric and neonatal patients. Students perceived simulation-based training as important in preparing them for placements.